US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
HOOKIPA Pharma Inc (HOOK)
HOOKIPA Pharma Inc (HOOK) ニュース

HOOK

HOOKIPA Pharma (HOOK)

HOOKIPA Pharma Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:HOOK

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/09	20 : 04	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/05/09	20 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/05/09	20 : 01	GlobeNewswire Inc.	HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/04/25	20 : 01	GlobeNewswire Inc.	HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/04/24	20 : 01	GlobeNewswire Inc.	HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/04/17	05 : 30	GlobeNewswire Inc.	HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/04/10	20 : 01	GlobeNewswire Inc.	HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/03/22	20 : 01	GlobeNewswire Inc.	HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/03/06	21 : 01	GlobeNewswire Inc.	HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/02/01	06 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/01/29	22 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/01/29	22 : 01	GlobeNewswire Inc.	HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/01/16	21 : 01	GlobeNewswire Inc.	HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/01/05	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/12/22	21 : 33	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/12/21	21 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/12/21	21 : 01	GlobeNewswire Inc.	HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead Sciences	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/12/02	06 : 46	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/11/20	21 : 01	GlobeNewswire Inc.	HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-500 for the Treatment of Human Immunodeficiency Virus	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/11/09	21 : 10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/11/09	21 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/11/09	21 : 01	GlobeNewswire Inc.	HOOKIPA Pharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/11/04	01 : 01	GlobeNewswire Inc.	HOOKIPA Pharma Presents Positive Biomarker and Translational Data on HB-200 Monotherapy at Society for Immunotherapy of Cancer 2023	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/11/03	05 : 01	GlobeNewswire Inc.	HOOKIPA Pharma to Report Third Quarter 2023 Financial Results and Recent Business Highlights on November 9, 2023	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/10/22	19 : 01	GlobeNewswire Inc.	HOOKIPA Pharma Presents Additional Preliminary Phase 2 Data on HB-200 in Combination with Pembrolizumab as First-Line Treatment in Patients with HPV16+ Head and Neck Cancers at European Society for Medical Oncology Congress 2023	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/10/21	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/10/18	20 : 01	GlobeNewswire Inc.	HOOKIPA Pharma announces publication of preclinical data of hepatitis B virus (HBV) therapeutic vaccine developed in collaboration with Gilead Sciences	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/09/13	21 : 47	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/09/13	21 : 45	GlobeNewswire Inc.	HOOKIPA Announces Executive Leadership Change	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/09/12	21 : 01	Edgar (US Regulatory)	Form SC TO-I/A - Tender offer statement by Issuer: [Amend]	NASDAQ:HOOK	HOOKIPA Pharma Inc

Showing the most relevant articles for your search:NASDAQ:HOOK

1 2 3 4 5 6 7 8 9 10 次へ >>

Column Small Cap Select

Structured Prdt W/I Tiers

Nord Precious Metals Min...

Bnp Paribas Issuance

Vontobel Financial Produ...

Vontobel Financial Produ...

BNP Paribas Issuance

Fidelity Advisor Global ...

JHSFE440 Ex:4,31

United Utilities (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約